• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Generic Biologics Face Uphill Battle

    Morningstar generic-pharmaceuticals analyst Brian Laegeler discusses the outlook for generic biologics in the U.S. given a strong branded-drug lobby and complex manufacturing processes.

  2. Going Global to Ease Drug Trial Process

    Contract research organization Parexel is exploiting its global footprint to rapidly enroll patients in drug studies.

  3. Lorillard Bonds Attractive Ahead of FDA Ruling

    Worries about the FDA's ruling on the relative safety of menthol cigarettes have left Lorillard's bonds looking attractively priced according to Morningstar's Dave Sekera.

  4. After Reform, Opportunity

    Associate director for health-care analysis Alex Morozov on the uncertainty-overhang relief, biggest winners, and best values in post-reform health care.

  1. Isis Pharmaceuticals ISIS Q2 2012 Earnings Call Transcript

    Good day, ladies and gentlemen, and welcome to Isis Pharmaceuticals' Second Quarter Financial Results Conference Call. Leading the call today from Isis is Dr. Stanley Crook, Isis's Chairman and Chief Executive Officer. Dr. Crook, please begin.

  2. Alexion Pharmaceuticals ALXN Q4 2012 Earnings Call Transcript

    Good morning and welcome to the Alexion Pharmaceuticals Incorporated Fourth Quarter and Full Year 2012 Results Conference Call. Today's call is being recorded.

  3. Cubist Pharmaceuticals, Inc. CBST Q2 2010 Earnings Call Transcript

    Greetings and welcome to the Cubist Pharmaceuticals' Second Quarter 2010 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Eileen McIntyre, for Cubist Pharmaceuticals. Thank you, you may begin.

  4. A Midyear Checkup on the Health-Care Sector

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.